Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
Owing to considerable differences observed in anatomy and physiology between paediatric subsets, it has been well established that children respond to drugs differently compared to adults. Furthermore, from a formulation perspective, there is a distinct challenge to develop a dosage form that is cap...
Main Authors: | Dilawar Khan, Daniel Kirby, Simon Bryson, Maryam Shah, Afzal Rahman Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/6/831 |
Similar Items
-
Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use
by: Dilawar Khan, et al.
Published: (2023-02-01) -
Quantification of Fluid Volume and Distribution in the Paediatric Colon via Magnetic Resonance Imaging
by: Jan Goelen, et al.
Published: (2021-10-01) -
Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
by: Jiayu Hu, et al.
Published: (2023-01-01) -
Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water
by: Toshihide Takagi, et al.
Published: (2023-08-01) -
Formulation and development of paediatric orally disintegrating carbamazepine tablets
by: R Canadell-Heredia, et al.
Published: (2022-11-01)